EUVIMEDEUVIMED entdecken
Crossref

Anti‐ MDA5 positivity: describing the frequency and spectrum of clinically evident MDA5 disease

Janelle See iD, Jessica L Fairley iD, Ai L Yeo, Samar Ojaimi, Eric F Morand iD

Internal Medicine Journal · 2024

DOI: 10.1111/imj.16563 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Internal Medicine Journal, 2024. Verfasst von Janelle See und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Monash Health, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Interferon-Induced Helicase, IFIH1, Autoantibodies. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 16 Literaturangaben. Gefördert von: NHMRC Postgraduate Scholarship, Australian Government Research Training Program Scholarship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To evaluate experience in a tertiary rheumatology service with melanoma differentiation‐association‐protein‐5 (MDA5) disease and testing, patients with positive autoantibody results were reviewed for the presence of clinical disease. Anti‐MDA5 positivity was detected in 2% of myositis‐specific antibody tests. Of these, 29% did not have features consistent with anti‐MDA5 disease. However, when present, MDA5 disease is severe with a high mortality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interferon-Induced Helicase, IFIH1AutoantibodiesHumansMaleFemaleMiddle AgedAdultAgedDEAD-box RNA HelicasesDermatomyositisMyositisRetrospective Studies

Stichwörter der Autor:innen

MDA5 diseasedermatomyositisinterstitial lung diseaserapidly progressive ILDtofacitinib

Substanzen

Interferon-Induced Helicase, IFIH1IFIH1 protein, humanAutoantibodiesDEAD-box RNA Helicases

Autor:innen und Institutionen

  • Department of Rheumatology, Monash Health, Melbourne, Victoria, Australia.
  • Department of Medicine, The University of Melbourne, Melbourne, Victoria, Australia.
  • Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia.
  • Monash Pathology, Monash Health, Melbourne, Victoria, Australia.

ORCID-Profile: Janelle See, Jessica L Fairley, Eric F Morand

Förderung

  • NHMRC Postgraduate Scholarship
  • Australian Government Research Training Program Scholarship

Zitieren

APA

See, J., Fairley, J. L., Yeo, A. L., Ojaimi, S., & Morand, E. F. (2024). Anti‐ MDA5 positivity: describing the frequency and spectrum of clinically evident MDA5 disease. Internal Medicine Journal. https://doi.org/10.1111/imj.16563

Vancouver

See J, Fairley JL, Yeo AL, Ojaimi S, Morand EF. Anti‐ MDA5 positivity: describing the frequency and spectrum of clinically evident MDA5 disease. Internal Medicine Journal. 2024. doi:10.1111/imj.16563

BibTeX
@article{See2024,
  author = {See, Janelle and Fairley, Jessica L and Yeo, Ai L and Ojaimi, Samar and Morand, Eric F},
  title = {Anti‐ MDA5 positivity: describing the frequency and spectrum of clinically evident MDA5 disease},
  journal = {Internal Medicine Journal},
  year = {2024},
  doi = {10.1111/imj.16563}
}
Kostenlos starten →